Development of Standard Operating Protocols for the Optimization of
Cannabis oil
cannabidiol
delta-9-tetrahydrocannabinol
galenic preparations
medical Cannabis
standard operating protocols
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2019
2019
Historique:
received:
15
03
2019
accepted:
29
05
2019
entrez:
12
7
2019
pubmed:
12
7
2019
medline:
12
7
2019
Statut:
epublish
Résumé
Under current legislation in Italy,
Identifiants
pubmed: 31293423
doi: 10.3389/fphar.2019.00701
pmc: PMC6603222
doi:
Types de publication
Journal Article
Langues
eng
Pagination
701Références
Clin Pharmacokinet. 2003;42(4):327-60
pubmed: 12648025
JAMA. 2015 Jun 23-30;313(24):2456-73
pubmed: 26103030
JAMA. 2015 Jun 23-30;313(24):2474-83
pubmed: 26103031
Nature. 2015 Sep 24;525(7570):S2-3
pubmed: 26398736
J Alzheimers Dis. 2016;51(1):15-9
pubmed: 26757043
J Pharm Biomed Anal. 2016 Sep 5;128:201-209
pubmed: 27268223
Clin Chem Lab Med. 2017 Aug 28;55(10):1555-1563
pubmed: 28207408
Cannabis Cannabinoid Res. 2016 Dec 01;1(1):262-271
pubmed: 28861498
J Pharm Pharmacol. 2018 Jan;70(1):143-149
pubmed: 29057480
Dialogues Clin Neurosci. 2017 Sep;19(3):309-316
pubmed: 29302228
Br J Clin Pharmacol. 2018 Nov;84(11):2458-2462
pubmed: 29859014
Ann Clin Transl Neurol. 2018 Aug 01;5(9):1077-1088
pubmed: 30250864
J Cell Physiol. 2019 Jun;234(6):8342-8351
pubmed: 30417354
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):348-352
pubmed: 30801394